Top 10 Companies in the Amikacin Sulfate Market (2025): Key Players Combatting Antimicrobial Resistance

In Business Insights
December 20, 2025


The Global Amikacin Sulfate Market was valued at USD 248.9 Million in 2024 and is projected to reach USD 317.5 Million by 2029, growing at a Compound Annual Growth Rate (CAGR) of 4.1% during the forecast period (2024–2029). This growth is propelled by the escalating global threat of antimicrobial resistance (AMR), the increasing incidence of severe gram-negative bacterial infections, and the critical role of aminoglycosides like Amikacin in hospital-acquired infection protocols.

As healthcare systems worldwide intensify their fight against drug-resistant superbugs, the pharmaceutical companies manufacturing this essential injectable antibiotic are at the forefront of a critical public health battle. In this blog, we profile the Top 10 Companies in the Amikacin Sulfate Industry—a mix of established pharmaceutical giants and specialized API producers ensuring a steady supply of this life-saving medication.


🔟 1. Chengdu Brilliant Pharmaceutical Group

Headquarters: Chengdu, Sichuan, China
Key Offering: Amikacin Sulfate API, Finished Dosage Forms

Chengdu Brilliant Pharmaceutical Group is a leading manufacturer of pharmaceutical raw materials and intermediates, with a strong focus on antibiotics. The company produces high-purity Amikacin Sulfate that meets international pharmacopeia standards (USP, EP), supplying both domestic Chinese markets and global pharmaceutical partners.

Strategic Initiatives:

  • Investment in advanced purification technologies for higher yield

  • Expansion of cGMP-compliant manufacturing capacities

  • Strategic partnerships with multinational pharmaceutical companies

Download FREE Sample Report:
Amikacin Sulfate Market – View in Detailed Research Report


9️⃣ 2. Chongqing Daxin Pharmaceutical Co., Ltd.

Headquarters: Chongqing, China
Key Offering: Amikacin Sulfate API and Injections

Chongqing Daxin Pharmaceutical specializes in the research, production, and sale of aminoglycoside antibiotics. The company has a robust vertical integration strategy, controlling the production process from basic chemical synthesis to the final sterile injectable product, ensuring stringent quality control.

Strategic Initiatives:

  • Focus on cost-effective manufacturing processes

  • Strengthening distribution networks across Asia and emerging markets


8️⃣ 3. Interquim Mexico (A member of the Viatris network)

Headquarters: Mexico City, Mexico
Key Offering: High-Purity Amikacin Sulfate

Interquim Mexico is a key player in the Latin American pharmaceutical ingredients market. As part of a broader network, it plays a crucial role in the regional supply chain for essential medicines, including Amikacin Sulfate, serving both public health tenders and private sector needs.

Strategic Initiatives:

  • Leveraging regional manufacturing advantages for North and South American markets

  • Adherence to FDA and COFEPRIS regulatory standards


7️⃣ 4. CONBA Group (Zhejiang Conba Pharmaceutical)

Headquarters: Hangzhou, Zhejiang, China
Key Offering: Amikacin Sulfate API and Finished Products

CONBA Group is one of China’s top pharmaceutical enterprises with a diverse portfolio that includes modernized traditional Chinese medicine, chemical APIs, and biological medicines. Its chemical division is a significant producer of Amikacin Sulfate, leveraging large-scale production capabilities.

Strategic Initiatives:

  • Continuous process optimization for environmental sustainability

  • R&D focused on improving the safety profile of aminoglycosides

Download FREE Sample Report:
Amikacin Sulfate Market – View in Detailed Research Report


6️⃣ 5. Suanfarma

Headquarters: Madrid, Spain
Key Offering: Amikacin Sulfate and other API

Suanfarma is a Spanish company dedicated to the development, manufacture, and marketing of active pharmaceutical ingredients (APIs). With a strong presence in Europe and a commitment to high-quality standards, Suanfarma is a reliable supplier of Amikacin Sulfate to the European pharmaceutical market.

Strategic Initiatives:

  • Emphasis on European regulatory compliance (EMA)

  • Building long-term supply agreements with European generic drug manufacturers


5️⃣ 6. HangZhou HuiSheng Biotech Pharmaceutical Co., Ltd.

Headquarters: Hangzhou, Zhejiang, China
Key Offering: Amikacin Sulfate and specialty biochemicals

HangZhou HuiSheng Biotech specializes in the research and production of pharmaceutical intermediates and APIs. The company has carved a niche with its technical expertise in the synthesis of complex molecules like Amikacin Sulfate, focusing on purity and consistency.

Strategic Initiatives:

  • Investment in R&D for novel synthetic pathways

  • Targeting niche markets with high-quality, customized offerings


4️⃣ 7. Iffect Chemphar Co., Ltd.

Headquarters: Wuhan, Hubei, China
Key Offering: Amikacin Sulfate API

Iffect Chemphar is a dynamic manufacturer and supplier of pharmaceutical raw materials, including a range of antibiotic APIs. The company is recognized for its responsive supply chain and ability to meet the specific quality requirements of international clients.

Strategic Initiatives:

  • Development of a robust global export strategy

  • Focus on competitive pricing while maintaining quality


3️⃣ 8. Triveni Interchem Pvt. Ltd.

Headquarters: Vapi, Gujarat, India
Key Offering: Amikacin Sulfate and other pharmaceutical intermediates

Triveni Interchem is a prominent Indian manufacturer of APIs and intermediates. The company benefits from India’s strong chemical industry base and expertise, making it a competitive supplier in the global market for Amikacin Sulfate.

Strategic Initiatives:

  • Leveraging cost advantages of Indian manufacturing

  • Expanding regulatory filings in key international markets


2️⃣ 9. NC Pharm (Northeast Pharmaceutical Group)

Headquarters: Shenyang, Liaoning, China
Key Offering: Amikacin Sulfate API and Formulations

NC Pharm is a large-scale state-owned pharmaceutical group in China with a long history in antibiotic production. The company possesses comprehensive capabilities from API synthesis to the manufacturing of various dosage forms, including injections.

Strategic Initiatives:

  • Modernization of legacy production facilities

  • Strategic focus on supplying China’s vast domestic healthcare market


1️⃣ 10. Qilu Pharmaceutical Co., Ltd.

Headquarters: Jinan, Shandong, China
Key Offering: Amikacin Sulfate Injections and APIs

Qilu Pharmaceutical is a leading and diversified pharmaceutical company in China, renowned for its extensive product portfolio and strong R&D capabilities. It is a major producer of Amikacin Sulfate, supplying hospitals across China and internationally.

Strategic Initiatives:

  • Significant investment in new drug delivery systems for existing antibiotics

  • Expansion of international regulatory approvals for its finished products

Get Full Report Here:
Amikacin Sulfate Market – View in Detailed Research Report


🌍 Outlook: The Critical Role of Amikacin Sulfate in Modern Healthcare

The Amikacin Sulfate market is characterized by steady demand driven by its irreplaceable role in the antimicrobial arsenal. While generic and competitive, the market’s dynamics are heavily influenced by global health priorities, regulatory landscapes, and manufacturing excellence.

📈 Key Trends Shaping the Market:

  • Rising global incidence of Multi-Drug Resistant (MDR) Gram-negative infections

  • Increasing use in combination therapies for complicated infections

  • Stringent regulatory scrutiny on API quality and manufacturing practices

  • Growth in hospital infrastructure and critical care units in emerging economies

Get Full Report Here:
Amikacin Sulfate Market – View in Detailed Research Report

The companies listed above are not only key suppliers of a vital antibiotic—they are essential partners in the global effort to combat antimicrobial resistance and save lives.